Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Mettl13em1flox/Cya
Common Name:
Mettl13-flox
Product ID:
S-CKO-15077
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Mettl13-flox
Strain ID
CKOCMP-71449-Mettl13-B6J-VA
Gene Name
Mettl13
Product ID
S-CKO-15077
Gene Alias
5630401D24Rik; Eef1aknmt
Background
C57BL/6JCya
NCBI ID
71449
Modification
Conditional knockout
Chromosome
1
Phenotype
MGI:1918699
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Mettl13em1flox/Cya mice (Catalog S-CKO-15077) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000028017
NCBI RefSeq
NM_144877
Target Region
Exon 2
Size of Effective Region
~1.3 kb
Detailed Document
Click here to download >>
Overview of Gene Research
METTL13, also known as eEF1A-KNMT and FEAT, is a dual methyltransferase. It targets the N-terminus and Lys55 in eukaryotic translation elongation factor 1 alpha (eEF1A). METTL13-mediated methylation of eEF1A impacts translation dynamics, including the rate of global protein synthesis and translation of specific codons, and is associated with multiple biological processes and diseases, especially cancers [5].

In Ras-driven cancers, METTL13 deletion and eEF1AK55me2 loss significantly reduce neoplastic growth in mouse models and patient-derived xenografts (PDXs) from primary pancreatic and lung tumors, indicating its role in promoting tumorigenesis through increasing translational output [1]. In nasopharyngeal carcinoma (NPC) cells, METTL13 silencing suppresses cellular phenotypes like proliferation, migration, invasion, and angiogenesis in vitro and hinders tumorigenesis in vivo [2]. In gastric cancer, silencing METTL13 suppresses cell proliferation and metastasis in vivo and vitro [4]. In clear cell renal cell carcinoma (ccRCC), knockdown and overexpression of METTL13 respectively lead to an increase and decrease in ccRCC cells' proliferation, viability, migratory and invasive abilities, as well as epithelial-mesenchymal transition (EMT) in vitro, and METTL13 inhibits ccRCC cells' growth and metastasis in vivo [6]. In bladder carcinoma, although the original study was retracted, it was initially reported that METTL13 negatively regulated cell proliferation, migration, and invasion [7,8]. In the heart, cardiomyocyte-specific overexpression of Mettl13 attenuated cardiac contractile dysfunction and fibrosis in response to myocardial infarction in mice, while silencing impaired cardiac function [3].

In conclusion, METTL13 plays a crucial role in multiple biological processes, especially in cancer and cardiac function. Studies using gene knockout or knockdown models in mice and in vitro cell models have revealed its oncogenic or tumor-suppressive roles in different cancers and its protective role in ischemic heart failure, providing potential therapeutic targets for these diseases.

References:
1. Liu, Shuo, Hausmann, Simone, Carlson, Scott Moore, Mazur, Pawel Karol, Gozani, Or. 2019. METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. In Cell, 176, 491-504.e21. doi:10.1016/j.cell.2018.11.038. https://pubmed.ncbi.nlm.nih.gov/30612740/
2. Ni, Haifeng, Liang, Chengxian, Zhou, Zhen, Shang, Haiqiong, Yu, Xiaoyu. 2023. METTL13 promotes nasopharyngeal carcinoma progression through regulating the ZEB1/TPT1 axis. In The journal of gene medicine, 25, e3476. doi:10.1002/jgm.3476. https://pubmed.ncbi.nlm.nih.gov/36735630/
3. Yu, Shuting, Sun, ZhiYong, Wang, Xiuzhu, Yang, Baofeng, Du, Weijie. 2023. Mettl13 protects against cardiac contractile dysfunction by negatively regulating C-Cbl-mediated ubiquitination of SERCA2a in ischemic heart failure. In Science China. Life sciences, 66, 2786-2804. doi:10.1007/s11427-022-2351-1. https://pubmed.ncbi.nlm.nih.gov/37450238/
4. Wu, Qiong, Hu, Qingqing, Hai, Yanan, Li, Yandong, Gao, Yong. 2022. METTL13 facilitates cell growth and metastasis in gastric cancer via an eEF1A/HN1L positive feedback circuit. In Journal of cell communication and signaling, 17, 121-135. doi:10.1007/s12079-022-00687-x. https://pubmed.ncbi.nlm.nih.gov/35925508/
5. Jakobsson, Magnus E. 2021. Structure, Activity and Function of the Dual Protein Lysine and Protein N-Terminal Methyltransferase METTL13. In Life (Basel, Switzerland), 11, . doi:10.3390/life11111121. https://pubmed.ncbi.nlm.nih.gov/34832997/
6. Liu, Zhuonan, Sun, Tianshui, Piao, Chiyuan, Zhang, Zhe, Kong, Chuize. 2021. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression. In Journal of translational medicine, 19, 209. doi:10.1186/s12967-021-02879-2. https://pubmed.ncbi.nlm.nih.gov/33985542/
7. Zhang, Zhe, Zhang, Guojun, Kong, Chuize, Dong, Xiao, Man, Xiaojun. 2016. METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion. In Scientific reports, 6, 19261. doi:10.1038/srep19261. https://pubmed.ncbi.nlm.nih.gov/26763933/
8. Zhang, Zhe, Zhang, Guojun, Kong, Chuize, Dong, Xiao, Man, Xiaojun. 2023. Retraction Note: METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion. In Scientific reports, 13, 11916. doi:10.1038/s41598-023-39010-y. https://pubmed.ncbi.nlm.nih.gov/37488192/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest